References
- Aoyama T., Nagata K., Yamazoe Y., Kato R., Matsunaga E., Gelboin H.V., Gonzalez F.J. Cytochrome b5 potentiation of cytochrome P-450 catalytic activity demonstrated by a vaccinia virus-mediated in situ reconstitution system. Proceedings of the National Academy of Sciences 1990; 87: 5425–5429
- Ged C., Umbenhauer D.R., Beelew T.M., Bork R.W., Sirvastava P.K., Shinriki N., Lloyd R.S., Guengerich F.P. Characterization of cDNAs, mRNAs, and proteins related to human liver microsomal cytochrome P-450 (S)-mephenytoin 4′-hydroxylase. Biochemistry 1988; 27: 6929–6940
- Kato R., Yasumori T., Yamozoe Y. Characterization of human P-450IIC isozyme by using a yeast expression system. Methods in Enzymology 1991; 206: 183–190
- Kawano S., Kamataki T., Yasumori T., Yamazoe Y., Kato R. Purification of human liver cytochrome P-450 catalyzing testosterone 6β-hydroxylation. Journal of Biochemistry 1987; 102: 493–501
- Kimura S., Pastewka J., Gelvoin H.V., Gonzalez F.J. cDNA and amino acid sequences of two members of the human P-450IIC gene subfamily. Nucleic Acids Research 1987; 15: 10053–10054
- Knodell R.G., Dubey R.K., Wilkinson G.R., Guengerich F.P. Oxidative metabolism of hexobarbital in human liver: relationship to polymorphic S-mephenytoin 4-hydroxylation. Journal of Pharmacology and Experimental Therapeutics 1988; 245: 845–849
- Kupfer A., Preisig R. Pharmacogenetics of mephenytoin: a new drug hydroxylation polymorphism in man. European Journal of Clinical Pharmacology 1984; 26: 753–759
- Kupfer A., Roberts R.K., Schenker S., Branch R.A. Stereoselective metabolism of mephenytoin in man. Journal of Pharmacology and Experimental Therapeutics 1981; 218: 193–199
- Meehan R.R., Gossen J.R., Rout D., Hastie N.D., Friedberg T., Adesnik M., Buckland R., Van Heyningen V., Fletcher J., Spurr N., Sweeney J., Wolf C.R. Human cytochrome P-450 PB-1: a multigene family involved in mephenytoin and steroid oxidations that maps to chromosome 10. American Journal of Human Genetics 1988; 42: 26–37
- Nakamura K., Goto F., Ray W.A., McAllister C.B., Jacqz E., Wilkinson G.R., Branch R.A. Interethnic differences in genetic polymorphism of debrisoquin and mephenytoin hydroxylation between Japanese and Caucasian populations. Clinical Pharmacology and Therapeutics 1985; 38: 402–408
- Ohgiya S., Komori M., Fujitani T., Miura T., Shinriki N., Kamataki T. Cloning of human cytochrome P-450 cDNA and its expression in Saccharomyces cerevisiae. Biochemistry International 1989; 18: 429–438
- Umbenhauer D.R., Martin M.V., Lloyd R.S., Guengerich F.P. Cloning and sequence determination of a complementary DNA related to human liver microsomal cytochrome P-450 S-mephenytoin 4-hydroxylase. Biochemistry 1987; 26: 1094–1099
- Yamazoe Y., Murayama N., Shimada M., Yamauchi K., Nagata K., Imaoka S., Funae Y., Kato R. A sex-specific form of cytochrome P-450 catalyzing propoxycoumarin O-depropylation and its identity with testosterone 6β-hydroxylase in untreated rat livers: reconstitution of the activity with microsomal lipids. Journal of Biochemistry 1988; 104: 785–790
- Yasumori T., Kawano S., Nagata K., Shimada M., Yamazoe Y., Kato R. Nucleotide sequence of a human liver cytochrome P-450 related to the rat male specific form. Journal of Biochemistry 1987; 102: 1075–1082
- Yasumori T., Murayama N., Yamazoe Y., Abe A., Nogi Y., Fukasawa T., Kato R. Expression of a human P-450IIC gene in yeast cells using galactose-inducible expression system. Molecular Pharmacology 1989; 35: 443–449
- Yasumori T., Murayama N., Yamazoe Y., Kato R. Polymorphism in hydroxylation of mephenytoin and hexobarbital stereoisomers in relation to hepatic P-450 human-2. Clinical Pharmacology and Therapeutics 1990; 47: 313–322
- Yasumori T., Yamazoe Y., Kato R. Cytochrome P-450 human-2 (P-450IIC9) in mephenytoin hydroxylation polymorphism in human livers: Differences in substrate and stereoselectivities among microheterogeneous P-450IIC species expressed in yeasts. Journal of Biochemistry 1991; 109: 711–717